CMI, while calling it a milestone, said the approval comes after the company received IDE approvals for Magic Touch SCB to treat coronary in-stent restenosis (ISR) in September 2022 and Magic Touch ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback